AllianceBernstein’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$335K Buy
296,498
+108,090
+57% +$122K ﹤0.01% 2862
2025
Q1
$275K Sell
188,408
-21,670
-10% -$31.6K ﹤0.01% 2818
2024
Q4
$447K Hold
210,078
﹤0.01% 2688
2024
Q3
$588K Hold
210,078
﹤0.01% 2582
2024
Q2
$489K Buy
210,078
+55,270
+36% +$129K ﹤0.01% 2682
2024
Q1
$692K Hold
154,808
﹤0.01% 2441
2023
Q4
$497K Buy
154,808
+10,090
+7% +$32.4K ﹤0.01% 2612
2023
Q3
$459K Sell
144,718
-18,630
-11% -$59.1K ﹤0.01% 2606
2023
Q2
$812K Buy
163,348
+62,440
+62% +$310K ﹤0.01% 2387
2023
Q1
$498K Buy
100,908
+14,800
+17% +$73.1K ﹤0.01% 2578
2022
Q4
$542K Sell
86,108
-411
-0.5% -$2.59K ﹤0.01% 2587
2022
Q3
$934K Sell
86,519
-542,988
-86% -$5.86M ﹤0.01% 2317
2022
Q2
$7.18M Buy
629,507
+538,699
+593% +$6.14M ﹤0.01% 1274
2022
Q1
$827K Buy
90,808
+100
+0.1% +$911 ﹤0.01% 2480
2021
Q4
$1.35M Sell
90,708
-3,126,577
-97% -$46.6M ﹤0.01% 2342
2021
Q3
$82.7M Buy
3,217,285
+50,655
+2% +$1.3M 0.03% 481
2021
Q2
$82.6M Buy
3,166,630
+625,071
+25% +$16.3M 0.03% 486
2021
Q1
$89.7M Sell
2,541,559
-47,299
-2% -$1.67M 0.04% 433
2020
Q4
$65.3M Buy
2,588,858
+654,713
+34% +$16.5M 0.03% 497
2020
Q3
$72.9M Buy
1,934,145
+231,025
+14% +$8.71M 0.04% 428
2020
Q2
$72.9M Sell
1,703,120
-273,604
-14% -$11.7M 0.04% 418
2020
Q1
$38.4M Buy
1,976,724
+200,421
+11% +$3.9M 0.03% 516
2019
Q4
$46.1M Buy
1,776,303
+162,594
+10% +$4.22M 0.03% 565
2019
Q3
$44M Buy
1,613,709
+84,060
+5% +$2.29M 0.03% 561
2019
Q2
$41.1M Buy
1,529,649
+164,642
+12% +$4.42M 0.03% 594
2019
Q1
$39.5M Buy
1,365,007
+79,580
+6% +$2.3M 0.03% 595
2018
Q4
$34.6M Buy
+1,285,427
New +$34.6M 0.03% 591